MANGALAM

Mangalam Drugs and Organics

₹113.55
-4.5 (-3.81%)
24 May, 2024 04:43 BSE: 532637 NSE: MANGALAMISIN: INE584F01014

Start SIP in Mangalam Drugs and Organics

Start SIP

Mangalam Drugs and Organics Performance

Day Range

  • Low 112
  • High 127
₹ 113

52 Week Range

  • Low 91
  • High 132
₹ 113
  • Open Price127
  • Previous Close118
  • Volume560022

Mangalam Drugs and Organics Share Price

  • Over 1 Month +13.44%
  • Over 3 Month -9.74%
  • Over 6 Month +19.28%
  • Over 1 Year +7.12%

Mangalam Drugs and Organics Key Statistics

P/E Ratio -19.9
PEG Ratio 0
Market Cap Cr 180
Price to Book Ratio 1.3
EPS -5.7
Dividend 0
Relative Strength Index 65.82
Money Flow Index 91.02
MACD Signal -0.18
Average True Range 5.47
Mangalam Drugs and Organics Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 10297828790
Operating Expenses Qtr Cr 9190799191
Operating Profit Qtr Cr 1272-30
Depreciation Qtr Cr 44433
Interest Qtr Cr 43333
Tax Qtr Cr 00-1-1-1
Net Profit Qtr Cr 41-4-10-4
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 369373
Operating Expenses Annual Cr 351347
Operating Profit Annual in Cr 1726
Depreciation Cr 1511
Interest Annual Cr 1413
Tax Annual Cr -21
Net Profit Annual Cr -91
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 1240
Cash from Investing Activity Annual Cr -18-22
Cash from Financing Annual Activity Cr 6-17
Net Cash Flow Annual Cr 1
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 142152
Fixed Assets Annual Cr 132152
Total Non Current Assets Annual Cr 157153
Total Current Assets Annual Cr 200207
Total Assets Annual Cr 357360
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 9096
ROE Annual % -61
ROCE Annual % 28
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 57
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 10297
Operating Expenses Qtr Cr 9190
Operating Profit Qtr Cr 127
Depreciation Qtr Cr 44
Interest Qtr Cr 43
Tax Qtr Cr 00
Net Profit Qtr Cr 40
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 369
Operating Expenses Annual Cr 351
Operating Profit Annual in Cr 17
Depreciation Cr 15
Interest Annual Cr 14
Tax Annual Cr -2
Net Profit Annual Cr -9
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr -11
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 136
Fixed Assets Annual Cr 133
Total Non Current Assets Annual Cr 158
Total Current Assets Annual Cr 176
Total Assets Annual Cr 333
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 86
ROE Annual % -7
ROCE Annual % 2
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 5

Mangalam Drugs and Organics Technicals

EMA & SMA

Current Price
₹113.55
-4.5 (-3.81%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹102.37
  • 50 Day
  • ₹102.61
  • 100 Day
  • ₹103.65
  • 200 Day
  • ₹105.54
  • 20 Day
  • ₹100.96
  • 50 Day
  • ₹100.62
  • 100 Day
  • ₹105.44
  • 200 Day
  • ₹103.64

Mangalam Drugs and Organics Resistance and Support

PIVOT
₹117.55
Resistance
First Resistance 123.00
Second Resistance 132.45
Third Resistance 137.90
RSI 65.82
MFI 91.02
MACD Single Line -0.18
MACD 1.69
Support
First Support 108.10
Second Support 102.65
Third Supoort 93.20

Mangalam Drugs and Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 617,122 31,362,140 50.82
Week 290,400 14,557,732 50.13
1 Month 92,117 4,873,926 52.91
6 Month 116,519 5,977,447 51.3

Mangalam Drugs and Organics Result Highlights

Mangalam Drugs and Organics Synopsis

NSE-Medical-Generic Drugs

Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 372.25 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2023. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
Market Cap 180
Sales 369
Shares in Float 0.79
No of funds 5
Yield 0.68
Book Value 1.25
U/D Vol ratio 0.9
LTDebt / Equity 9
Alpha -0.16
Beta 1.14

Mangalam Drugs and Organics Shareholding Pattern

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 50.32%50.32%50.32%50.32%
Foreign Portfolio Investors 0.26%0.1%0.1%0.1%
Financial Institutions/ Banks
Individual Investors 44.22%44.44%44.55%44.64%
Others 5.2%5.14%5.03%4.94%

Mangalam Drugs and Organics Management

Name Designation
Mr. Govardhan M Dhoot Chairman & Managing Director
Mr. Brijmohan M Dhoot Whole Time Director
Mr. Rakesh K Milwani Non Exe.Non Ind.Director
Mr. Rukmesh P Dhandhania Independent Director
Mrs. Nidhi S Mundada Independent Director
Mr. Praveen Saxena Independent Director

Mangalam Drugs and Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Mangalam Drugs and Organics Corporate Action

Date Purpose Remarks
2024-05-21 Audited Results
2024-03-15 Others Inter alia to consider and approve: The proposal of Scheme of Merger.
2024-02-13 Quarterly Results
2023-11-08 Quarterly Results
2023-08-10 Quarterly Results

Mangalam Drugs and Organics MF Shareholding

Name Amount(cr)

Mangalam Drugs and Organics FAQs

What is Share Price of Mangalam Drugs and Organics ?

Mangalam Drugs and Organics share price is ₹113 As on 24 May, 2024 | 04:29

What is the Market Cap of Mangalam Drugs and Organics ?

The Market Cap of Mangalam Drugs and Organics is ₹179.7 Cr As on 24 May, 2024 | 04:29

What is the P/E ratio of Mangalam Drugs and Organics ?

The P/E ratio of Mangalam Drugs and Organics is -19.9 As on 24 May, 2024 | 04:29

What is the PB ratio of Mangalam Drugs and Organics ?

The PB ratio of Mangalam Drugs and Organics is 1.3 As on 24 May, 2024 | 04:29

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91